ArticleEMBO molecular medicine2021

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer.

Weiqiang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.